Learning · Jun 9, 2026

FN MISSED REVIEW session

← All reports
0
Entered
479
Rejected
99
Missed (high sev)
578
News events
Missed high-severity headlines

99 candidates

TickerThemeHeadlineWhy
INTC general_catalyst Bad News For Bulls: BTIG Nailed Tuesday's Nasdaq Selloff missed due to scanner gap or no decision
FEE general_catalyst 'US judge OKs Visa, Mastercard $38 billion swipe fee settlement' - Reuters missed due to scanner gap or no decision
SWIPE general_catalyst 'US judge OKs Visa, Mastercard $38 billion swipe fee settlement' - Reuters missed due to scanner gap or no decision
VISA general_catalyst 'US judge OKs Visa, Mastercard $38 billion swipe fee settlement' - Reuters missed due to scanner gap or no decision
OKS general_catalyst 'US judge OKs Visa, Mastercard $38 billion swipe fee settlement' - Reuters missed due to scanner gap or no decision
JUDGE general_catalyst 'US judge OKs Visa, Mastercard $38 billion swipe fee settlement' - Reuters missed due to scanner gap or no decision
MRK general_catalyst Gilead And Merck End Trodelvy-Keytruda Lung Cancer Trial missed due to scanner gap or no decision
BA general_catalyst Boeing Delivers 60 Planes In May, Including 51 737 MAX Jets missed due to scanner gap or no decision
BTIG general_catalyst Bad News For Bulls: BTIG Nailed Tuesday's Nasdaq Selloff missed due to scanner gap or no decision
BULLS general_catalyst Bad News For Bulls: BTIG Nailed Tuesday's Nasdaq Selloff missed due to scanner gap or no decision
NEWS general_catalyst Bad News For Bulls: BTIG Nailed Tuesday's Nasdaq Selloff missed due to scanner gap or no decision
BAD general_catalyst Bad News For Bulls: BTIG Nailed Tuesday's Nasdaq Selloff missed due to scanner gap or no decision
MSFT general_catalyst Tech Stocks' Relief Rally Crumbles: SOXL Craters 15%, AMD Sheds 6% As Recovery Fizzles missed due to scanner gap or no decision
INTC general_catalyst Tech Stocks' Relief Rally Crumbles: SOXL Craters 15%, AMD Sheds 6% As Recovery Fizzles missed due to scanner gap or no decision
AAPL general_catalyst Tech Stocks' Relief Rally Crumbles: SOXL Craters 15%, AMD Sheds 6% As Recovery Fizzles missed due to scanner gap or no decision
TRIAL general_catalyst Gilead And Merck End Trodelvy-Keytruda Lung Cancer Trial missed due to scanner gap or no decision
LUNG general_catalyst Gilead And Merck End Trodelvy-Keytruda Lung Cancer Trial missed due to scanner gap or no decision
END general_catalyst Gilead And Merck End Trodelvy-Keytruda Lung Cancer Trial missed due to scanner gap or no decision
MERCK general_catalyst Gilead And Merck End Trodelvy-Keytruda Lung Cancer Trial missed due to scanner gap or no decision
CRM general_catalyst 'Salesforce Lays Off Employees In A New Round Of Cuts' - Business Insider missed due to scanner gap or no decision
OIL oil_supply_or_geopolitical_shock Shares of specialty retail companies are trading higher as oil prices and bond yields retreat amid optimism for a lastin missed due to scanner gap or no decision
AS oil_supply_or_geopolitical_shock Shares of specialty retail companies are trading higher as oil prices and bond yields retreat amid optimism for a lastin missed due to scanner gap or no decision
AS general_catalyst Tech Stocks' Relief Rally Crumbles: SOXL Craters 15%, AMD Sheds 6% As Recovery Fizzles missed due to scanner gap or no decision
SHEDS general_catalyst Tech Stocks' Relief Rally Crumbles: SOXL Craters 15%, AMD Sheds 6% As Recovery Fizzles missed due to scanner gap or no decision
AMD general_catalyst Tech Stocks' Relief Rally Crumbles: SOXL Craters 15%, AMD Sheds 6% As Recovery Fizzles missed due to scanner gap or no decision
SOXL general_catalyst Tech Stocks' Relief Rally Crumbles: SOXL Craters 15%, AMD Sheds 6% As Recovery Fizzles missed due to scanner gap or no decision
RALLY general_catalyst Tech Stocks' Relief Rally Crumbles: SOXL Craters 15%, AMD Sheds 6% As Recovery Fizzles missed due to scanner gap or no decision
TECH general_catalyst Tech Stocks' Relief Rally Crumbles: SOXL Craters 15%, AMD Sheds 6% As Recovery Fizzles missed due to scanner gap or no decision
CUTS general_catalyst 'Salesforce Lays Off Employees In A New Round Of Cuts' - Business Insider missed due to scanner gap or no decision
OF general_catalyst 'Salesforce Lays Off Employees In A New Round Of Cuts' - Business Insider missed due to scanner gap or no decision
ROUND general_catalyst 'Salesforce Lays Off Employees In A New Round Of Cuts' - Business Insider missed due to scanner gap or no decision
IN general_catalyst 'Salesforce Lays Off Employees In A New Round Of Cuts' - Business Insider missed due to scanner gap or no decision
OFF general_catalyst 'Salesforce Lays Off Employees In A New Round Of Cuts' - Business Insider missed due to scanner gap or no decision
LAYS general_catalyst 'Salesforce Lays Off Employees In A New Round Of Cuts' - Business Insider missed due to scanner gap or no decision
JNJ general_catalyst Johnson & Johnson's Nipocalimab Gets U.K.'s Medicines And Healthcare Products Regulatory Agency Authorization To Treat A missed due to scanner gap or no decision
JETS general_catalyst Boeing Delivers 60 Planes In May, Including 51 737 MAX Jets missed due to scanner gap or no decision
MAX general_catalyst Boeing Delivers 60 Planes In May, Including 51 737 MAX Jets missed due to scanner gap or no decision
GOOGL general_catalyst UPDATE: Zscaler Expands Project AI-Guardian With AWS, Google Cloud, OpenAI And Other Partners To Deliver Unified Zero-Tr missed due to scanner gap or no decision
AWS general_catalyst UPDATE: Zscaler Expands Project AI-Guardian With AWS, Google Cloud, OpenAI And Other Partners To Deliver Unified Zero-Tr missed due to scanner gap or no decision
UP general_catalyst This House of Representative Just Bought Up To $375K In Biogen Stock missed due to scanner gap or no decision
THIS general_catalyst This House of Representative Just Bought Up To $375K In Biogen Stock missed due to scanner gap or no decision
CRM surprise_M&A Salesforce To Acquire m3ter; Amount Not Disclosed missed due to scanner gap or no decision
MRK general_catalyst Gilead And Merck Report Phase 3 Results For Once-Weekly Oral HIV Regimen Islatravir/Lenacapavir; Meets Week 48 Endpoints missed due to scanner gap or no decision
XLE general_catalyst Johnson & Johnson's Nipocalimab Gets U.K.'s Medicines And Healthcare Products Regulatory Agency Authorization To Treat A missed due to scanner gap or no decision
WITH general_catalyst Johnson & Johnson's Nipocalimab Gets U.K.'s Medicines And Healthcare Products Regulatory Agency Authorization To Treat A missed due to scanner gap or no decision
TREAT general_catalyst Johnson & Johnson's Nipocalimab Gets U.K.'s Medicines And Healthcare Products Regulatory Agency Authorization To Treat A missed due to scanner gap or no decision
TO general_catalyst Johnson & Johnson's Nipocalimab Gets U.K.'s Medicines And Healthcare Products Regulatory Agency Authorization To Treat A missed due to scanner gap or no decision
GETS general_catalyst Johnson & Johnson's Nipocalimab Gets U.K.'s Medicines And Healthcare Products Regulatory Agency Authorization To Treat A missed due to scanner gap or no decision
TO surprise_M&A Salesforce To Acquire m3ter; Amount Not Disclosed missed due to scanner gap or no decision
INTC general_catalyst Cadence Expands Collaboration With Intel Foundry To Advance Design Technology Co-Optimization Targeting Intel's Next-Gen missed due to scanner gap or no decision
INTEL general_catalyst Cadence Expands Collaboration With Intel Foundry To Advance Design Technology Co-Optimization Targeting Intel's Next-Gen missed due to scanner gap or no decision
NSCLC general_catalyst Merck And Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Trial After Trodelvy–KEYTRUDA Combination Fails To Achieve Sta missed due to scanner gap or no decision
LINE general_catalyst Merck And Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Trial After Trodelvy–KEYTRUDA Combination Fails To Achieve Sta missed due to scanner gap or no decision
FIRST general_catalyst Merck And Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Trial After Trodelvy–KEYTRUDA Combination Fails To Achieve Sta missed due to scanner gap or no decision
IN general_catalyst Merck And Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Trial After Trodelvy–KEYTRUDA Combination Fails To Achieve Sta missed due to scanner gap or no decision
FREE general_catalyst Merck And Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Trial After Trodelvy–KEYTRUDA Combination Fails To Achieve Sta missed due to scanner gap or no decision
TO general_catalyst Merck And Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Trial After Trodelvy–KEYTRUDA Combination Fails To Achieve Sta missed due to scanner gap or no decision
FAILS general_catalyst Merck And Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Trial After Trodelvy–KEYTRUDA Combination Fails To Achieve Sta missed due to scanner gap or no decision
AFTER general_catalyst Merck And Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Trial After Trodelvy–KEYTRUDA Combination Fails To Achieve Sta missed due to scanner gap or no decision
TRIAL general_catalyst Merck And Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Trial After Trodelvy–KEYTRUDA Combination Fails To Achieve Sta missed due to scanner gap or no decision
EVOKE general_catalyst Merck And Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Trial After Trodelvy–KEYTRUDA Combination Fails To Achieve Sta missed due to scanner gap or no decision
PHASE general_catalyst Merck And Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Trial After Trodelvy–KEYTRUDA Combination Fails To Achieve Sta missed due to scanner gap or no decision
MERCK general_catalyst Merck And Gilead Discontinue Phase 3 KEYNOTE-D46/EVOKE-03 Trial After Trodelvy–KEYTRUDA Combination Fails To Achieve Sta missed due to scanner gap or no decision
IN general_catalyst Gilead And Merck Report Phase 3 Results For Once-Weekly Oral HIV Regimen Islatravir/Lenacapavir; Meets Week 48 Endpoints missed due to scanner gap or no decision
WEEK general_catalyst Gilead And Merck Report Phase 3 Results For Once-Weekly Oral HIV Regimen Islatravir/Lenacapavir; Meets Week 48 Endpoints missed due to scanner gap or no decision
MEETS general_catalyst Gilead And Merck Report Phase 3 Results For Once-Weekly Oral HIV Regimen Islatravir/Lenacapavir; Meets Week 48 Endpoints missed due to scanner gap or no decision
HIV general_catalyst Gilead And Merck Report Phase 3 Results For Once-Weekly Oral HIV Regimen Islatravir/Lenacapavir; Meets Week 48 Endpoints missed due to scanner gap or no decision
ORAL general_catalyst Gilead And Merck Report Phase 3 Results For Once-Weekly Oral HIV Regimen Islatravir/Lenacapavir; Meets Week 48 Endpoints missed due to scanner gap or no decision
ONCE general_catalyst Gilead And Merck Report Phase 3 Results For Once-Weekly Oral HIV Regimen Islatravir/Lenacapavir; Meets Week 48 Endpoints missed due to scanner gap or no decision
PHASE general_catalyst Gilead And Merck Report Phase 3 Results For Once-Weekly Oral HIV Regimen Islatravir/Lenacapavir; Meets Week 48 Endpoints missed due to scanner gap or no decision
MERCK general_catalyst Gilead And Merck Report Phase 3 Results For Once-Weekly Oral HIV Regimen Islatravir/Lenacapavir; Meets Week 48 Endpoints missed due to scanner gap or no decision
INTC general_catalyst Apple Introduces New AI Integration APIs And Expanded Agentic Coding Tools In Xcode 27, Enhancing App Development With A missed due to scanner gap or no decision
AAPL general_catalyst Apple Introduces New AI Integration APIs And Expanded Agentic Coding Tools In Xcode 27, Enhancing App Development With A missed due to scanner gap or no decision
APP general_catalyst Apple Introduces New AI Integration APIs And Expanded Agentic Coding Tools In Xcode 27, Enhancing App Development With A missed due to scanner gap or no decision
XCODE general_catalyst Apple Introduces New AI Integration APIs And Expanded Agentic Coding Tools In Xcode 27, Enhancing App Development With A missed due to scanner gap or no decision
IN general_catalyst Apple Introduces New AI Integration APIs And Expanded Agentic Coding Tools In Xcode 27, Enhancing App Development With A missed due to scanner gap or no decision
APIS general_catalyst Apple Introduces New AI Integration APIs And Expanded Agentic Coding Tools In Xcode 27, Enhancing App Development With A missed due to scanner gap or no decision
APPLE general_catalyst Apple Introduces New AI Integration APIs And Expanded Agentic Coding Tools In Xcode 27, Enhancing App Development With A missed due to scanner gap or no decision
AFTER general_catalyst OpenAI To Surpass $1.5 Trillion On Debut, Join Elite 'Mag 7' Ranks? Crypto Punters Lift Odds After Confidential IPO Fili missed due to scanner gap or no decision
ODDS general_catalyst OpenAI To Surpass $1.5 Trillion On Debut, Join Elite 'Mag 7' Ranks? Crypto Punters Lift Odds After Confidential IPO Fili missed due to scanner gap or no decision
LIFT general_catalyst OpenAI To Surpass $1.5 Trillion On Debut, Join Elite 'Mag 7' Ranks? Crypto Punters Lift Odds After Confidential IPO Fili missed due to scanner gap or no decision
RANKS general_catalyst OpenAI To Surpass $1.5 Trillion On Debut, Join Elite 'Mag 7' Ranks? Crypto Punters Lift Odds After Confidential IPO Fili missed due to scanner gap or no decision
MAG general_catalyst OpenAI To Surpass $1.5 Trillion On Debut, Join Elite 'Mag 7' Ranks? Crypto Punters Lift Odds After Confidential IPO Fili missed due to scanner gap or no decision
ELITE general_catalyst OpenAI To Surpass $1.5 Trillion On Debut, Join Elite 'Mag 7' Ranks? Crypto Punters Lift Odds After Confidential IPO Fili missed due to scanner gap or no decision
JOIN general_catalyst OpenAI To Surpass $1.5 Trillion On Debut, Join Elite 'Mag 7' Ranks? Crypto Punters Lift Odds After Confidential IPO Fili missed due to scanner gap or no decision
DEBUT general_catalyst OpenAI To Surpass $1.5 Trillion On Debut, Join Elite 'Mag 7' Ranks? Crypto Punters Lift Odds After Confidential IPO Fili missed due to scanner gap or no decision
ON general_catalyst OpenAI To Surpass $1.5 Trillion On Debut, Join Elite 'Mag 7' Ranks? Crypto Punters Lift Odds After Confidential IPO Fili missed due to scanner gap or no decision
TO general_catalyst OpenAI To Surpass $1.5 Trillion On Debut, Join Elite 'Mag 7' Ranks? Crypto Punters Lift Odds After Confidential IPO Fili missed due to scanner gap or no decision
AAPL AI_hardware_direct_catalyst Apple's Biggest AI Bet Yet Runs On NVIDIA, Not Its Own Chips missed due to scanner gap or no decision
CHIPS AI_hardware_direct_catalyst Apple's Biggest AI Bet Yet Runs On NVIDIA, Not Its Own Chips missed due to scanner gap or no decision
OWN AI_hardware_direct_catalyst Apple's Biggest AI Bet Yet Runs On NVIDIA, Not Its Own Chips missed due to scanner gap or no decision
ON AI_hardware_direct_catalyst Apple's Biggest AI Bet Yet Runs On NVIDIA, Not Its Own Chips missed due to scanner gap or no decision
RUNS AI_hardware_direct_catalyst Apple's Biggest AI Bet Yet Runs On NVIDIA, Not Its Own Chips missed due to scanner gap or no decision
YET AI_hardware_direct_catalyst Apple's Biggest AI Bet Yet Runs On NVIDIA, Not Its Own Chips missed due to scanner gap or no decision
BET AI_hardware_direct_catalyst Apple's Biggest AI Bet Yet Runs On NVIDIA, Not Its Own Chips missed due to scanner gap or no decision
APPLE AI_hardware_direct_catalyst Apple's Biggest AI Bet Yet Runs On NVIDIA, Not Its Own Chips missed due to scanner gap or no decision
QQQ AI_hardware_direct_catalyst Apple's Biggest AI Bet Yet Runs On NVIDIA, Not Its Own Chips missed due to scanner gap or no decision
SMH AI_hardware_direct_catalyst Apple's Biggest AI Bet Yet Runs On NVIDIA, Not Its Own Chips missed due to scanner gap or no decision
NVDA AI_hardware_direct_catalyst Apple's Biggest AI Bet Yet Runs On NVIDIA, Not Its Own Chips missed due to scanner gap or no decision
Reject reason counts

Today’s Fast News rejects

  • not worthy or duplicate 479
Rule suggestions

Manual approval required before production

  • fast_news missed_due_to_scanner_gap: add category or source for: general_catalyst, general_catalyst, general_catalyst, general_catalyst, general_catalyst